Hollywood, FL—In a study presented at the 2016 annual conference of the National Comprehensive Cancer Network, a real-world assessment of lenalidomide use in the treatment of patients with myelodysplastic syndrome (MDS) showed that dose modifications had a strong positive effect on outcomes.
Chicago, IL—A novel compound called CPX-351 that combines 2 older drugs (cytarabine and daunorubicin) in a new drug-delivery platform improved survival among older patients with newly diagnosed, high-risk (secondary) acute myeloid leukemia (AML), according to results of a phase 3 trial presented at the American Society of Clinical Oncology 2016 Annual Meeting.
Lymphomas, cancers that begin in lymphatic cells of the immune system, can be divided into 2 main categories: Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). Hodgkin lymphoma is a fairly homogeneous disease characterized by the presence of Reed-Sternberg cells. Hodgkin lymphoma is far less common than NHL—approximately 8000 new Hodgkin lymphoma cases are diagnosed in the United States annually compared with over 70,000 new cases of NHL; more than 60 types of lymphoma are included in the NHL category.1 Presented below are a few facts about various forms of lymphoma.
Results 31 - 40 of 149